Your Article Summary
See Latest ArticlesSafety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24—45 years: a randomised, double-blind trial
The Lancet, 06/08/09
Munoz N et al. - Although the peak incidence of human papillomavirus (HPV) infection occurs in most populations within 5—10 years of first sexual experience, all women remain at risk for acquisition of HPV infections. The authors tested the safety, immunogenicity, and efficacy of the quadrivalent HPV (types 6, 11, 16, 18) L1 virus-like-particle vaccine in women aged 24—45 years. The quadrivalent HPV vaccine is efficacious in women aged 24—45 years not infected with the relevant HPV types at enrolment.
Related Articles
Human papillomavirus infection in Beijing, People's Republic of China: a population-based study
British Journal of Cancer, 10/01/09
Relevance Score: 68%
Human Papillomavirus (HPV) Type 18 Induces Extended Growth in Primary Human Cervical, Tonsillar, or Foreskin Keratinocytes More Effectively than Other High-Risk Mucosal HPVs
Journal of Virology, 11/09/09
Relevance Score: 66%
Human Papillomavirus (HPV) Type 16 and Type 18 DNA Loads at Baseline and Persistence of Type-Specific Infection during a 2-Year Follow-Up
The Journal of Infectious Diseases, 10/29/09
Relevance Score: 66%
Human papillomavirus type 16 and 18 in primary lung cancers—a meta-analysis
Carcinogenesis, 10/12/09
Relevance Score: 66%
Human Papillomavirus Vaccine Uptake, Predictors of Vaccination, and Self-Reported Barriers to Vaccination
Journal of Women's Health, 10/05/09
Relevance Score: 66%
Today in Sexually Transmitted Dz...keeping you current
Receive free subspecialty "5-minute updates" via email
Identification and evaluation of a combination of chlamydial antigens to support the diagnosis of severe and invasive Chlamydia trachomatis infections
Clinical Microbiology and Infection, 12/14/09
HIV and Related Risk Behavior Among Men Who Have Sex with Men in Zanzibar, Tanzania: Results of a Behavioral Surveillance Survey
AIDS and Behavior, 12/14/09
Fibroblast growth factor-inducible 14 (Fn14) is expressed in the lower genital tract and may play a role in amplifying inflammation during infection
Journal of Reproductive Immunology, 12/07/09
Today in Urogenital...keeping you current
Receive free subspecialty "5-minute updates" via email
Is antibiotic prophylaxis effective in preventing urinary tract infections in patients with vesicoureteral reflux
Expert Review of Anti-infective Therapy, 12/17/09
Emergence of and risk factors for ciprofloxacin-gentamicin-resistant Escherichia coli urinary tract infections in a region of Quebec
Canadian Journal of Infectious Diseases, 12/17/09
Positive urine cultures: A major cause of inappropriate antimicrobial use in hospitals
Canadian Journal of Infectious Diseases, 12/15/09
Today in Vaccine/Immunotherapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Response to a Monovalent 2009 Influenza A (H1N1) Vaccine
New England Journal of Medicine, 12/17/09
A Novel Influenza A (H1N1) Vaccine in Various Age Groups
New England Journal of Medicine, 12/17/09
Trial of 2009 Influenza A (H1N1) Monovalent MF59-Adjuvanted Vaccine
New England Journal of Medicine, 12/17/09